|
13 Sep 2025 |
Lupin
|
Consensus Share Price Target
|
2043.40 |
2224.81 |
- |
8.88 |
buy
|
|
|
|
|
13 Feb 2023
|
Lupin
|
ICICI Securities Limited
|
2043.40
|
634.00
|
675.15
(202.66%)
|
Target met |
Sell
|
|
|
Lupin’s Q3FY23 performance was a beat on revenue front led by better than expected US sales. Revenue grew 3.9% YoY and 4.3% QoQ to Rs43.2bn (I-Sec: Rs41.4bn). US revenue was up 11.3% QoQ at US$177mn (I-Sec:US$172mn) led by new product launches (~US$20mn) and benefit from flu season.
|
|
12 Feb 2023
|
Lupin
|
Motilal Oswal
|
2043.40
|
610.00
|
737.15
(177.20%)
|
|
Sell
|
|
|
|
|
11 Feb 2023
|
Lupin
|
ICICI Direct
|
2043.40
|
725.00
|
737.15
(177.20%)
|
Target met |
Hold
|
|
|
|
|
10 Feb 2023
|
Lupin
|
Sharekhan
|
2043.40
|
660.00
|
658.05
(210.52%)
|
Target met |
Sell
|
|
|
|
|
11 Nov 2022
|
Lupin
|
Prabhudas Lilladhar
|
2043.40
|
650.00
|
759.50
(169.05%)
|
Target met |
Hold
|
|
|
|
|
11 Nov 2022
|
Lupin
|
ICICI Direct
|
2043.40
|
680.00
|
747.00
(173.55%)
|
Target met |
Sell
|
|
|
|
|
11 Nov 2022
|
Lupin
|
BOB Capital Markets Ltd.
|
2043.40
|
700.00
|
747.00
(173.55%)
|
Target met |
Hold
|
|
|
Q2 revenue grew 11% QoQ (+1% YoY) with recovery in US business and continued momentum in India
|
|
11 Nov 2022
|
Lupin
|
Axis Direct
|
2043.40
|
740.00
|
747.00
(173.55%)
|
Target met |
Hold
|
|
|
We expect the company to post stable margins due to improving volumes and a richer product mix. We maintain our HOLD rating on the stock with a revised TP of Rs 740/share.
|
|
11 Nov 2022
|
Lupin
|
ICICI Securities Limited
|
2043.40
|
626.00
|
719.35
(184.06%)
|
|
Sell
|
|
|
Lupin’s Q2FY23 performance was above our estimates with better than expected US sales. Revenue grew 1.3% YoY and 10.7% QoQ to Rs41.5bn (I-Sec: Rs39.7bn).
|
|
11 Aug 2022
|
Lupin
|
Geojit BNP Paribas
|
2043.40
|
720.00
|
682.85
(199.25%)
|
Target met |
Hold
|
|
|
|